Yes.
What we see is that with this cost-effectiveness comparison versus how much longer you are going to live, it just doesn't give the answers to help make decisions. If the drug isn't too expensive and it's going to let you live two months, well, great, there's no problem. So it really is about how much money.
So somehow or other this system--and the way we work and the way we make these decisions in Canada--is what needs to be fixed. Somebody said drilling down and looking at the process. I put in my notes a systemic re-look at what are our values, what are we valuing, and what is the value of life. I don't know the answer to it. These people have suggested some.
Sorry, I've finished.